Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Veritone Inc (VERI) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Veritone IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Veritone Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Veritone Inc trades at $0.53 (market cap $53.70M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 32.8× Veritone Inc's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Veritone Inc for 13 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

VERIVIR
Market Cap
$53.70M$1.76B
Volume
4,439,1042,764,948
Sector
TechnologyHealth
52-Week High
$8.39$11.78
52-Week Low
$0.53$5.12
Typical Hold Time
13 Days0 Days
Enterprise Value
$89.09M$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Veritone Inc

Veritone (VERI) trades at $0.59, down 2.64% on the day, with a bearish technical signal but oversold RSI readings. The company reported a net loss of $111.73M on $92.19M revenue in 2025, with negative cash flow from operations. Recent news includes a $15M equity offering and partnerships like the ATP Media deal, while facing a securities class action investigation.

The outlook remains challenged by persistent losses and cash burn, though analyst consensus is a Buy with a $3.75 price target. Key risks include execution on cost reductions, competitive pressures in AI, and legal overhangs. Upside hinges on revenue acceleration and path to profitability.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VERI
89% Buy11% Sell
Avg holding period · 13 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Veritone Inc

Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.

Read more on VERI →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →